News from accuray incorporated A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

May 17, 2022, 07:30 ET Accuray Appoints Sandeep Chalke as SVP, Chief Commercial Officer

Accuray Incorporated (NASDAQ: ARAY) announced today that Sandeep Chalke has joined the company as senior vice president, chief commercial officer...

May 10, 2022, 07:30 ET New Data Presented at ESTRO 2022 Reinforce Benefits of Accuray CyberKnife® and TomoTherapy® Platforms Across a Range of Indications and Complexities

Accuray Incorporated (NASDAQ: ARAY) announced today that clinical studies continue to validate the versatility of the company's CyberKnife® and...

May 05, 2022, 08:00 ET Accuray ClearRT™ Helical Fan-Beam kVCT Imaging Wins "Best New Technology Solution for Oncology" MedTech Breakthrough Award

Accuray Incorporated (NASDAQ: ARAY) announced today that its ClearRT™ helical fan-beam kVCT imaging capability for the Radixact® System has been...

Apr 27, 2022, 16:05 ET Accuray Announces Suzanne Winter, President, Promoted to President and CEO; Joshua Levine Will Retire as CEO and Board Member

Accuray Incorporated (NASDAQ: ARAY) announced today that Suzanne Winter, President, will succeed Joshua Levine as the company's Chief Executive...

Apr 27, 2022, 16:05 ET Accuray Reports Fiscal 2022 Third Quarter Financial Results

Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the third quarter of fiscal 2022 ended March 31, 2022. Third Quarter Fiscal...

Apr 21, 2022, 07:30 ET Owner of Arkansas Derby Winner Named Horse After the Life-Changing Accuray CyberKnife® Radiation Therapy Technology Used to Treat His Cancer

When Al Gold, the owner of the Arkansas Derby winner Cyberknife, received a diagnosis of prostate cancer, he was determined to find a potential cure...

Apr 13, 2022, 16:05 ET Accuray to Report Third Quarter Fiscal 2022 Financial Results on April 27, 2022

Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2022, ended March 31, 2022, after the market...

Mar 31, 2022, 07:30 ET 10-Year Data Shows Accuray CyberKnife® System Provides Long-Lasting Relief of the Excruciating Pain Caused by Trigeminal Neuralgia

Accuray Incorporated (NASDAQ: ARAY) announced today that long-term follow-up data from a study of men and women with trigeminal neuralgia (TN) showed ...

Mar 08, 2022, 07:30 ET CARTI Selects Accuray CyberKnife® S7™ System to Increase Access to Advanced Cancer Care for Patients in Rural Communities Throughout Arkansas

Accuray Incorporated (NASDAQ: ARAY) announced today that the CARTI medical care team in Little Rock, Arkansas has treated the first patients in the...

Feb 28, 2022, 07:30 ET NICE Endorses Radiosurgery Treatments for Trigeminal Neuralgia, Supporting Accuray CyberKnife® System Indications for Use

Accuray Incorporated (NASDAQ: ARAY) announced today that the National Institute for Health and Care Excellence (NICE)* has endorsed the use of...

Feb 24, 2022, 20:00 ET Accuray to Participate in the Cowen 42nd Annual Health Care Conference

Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the Cowen 42nd Annual Health Care Conference taking place March 7-9, 2022....

Feb 14, 2022, 16:10 ET Largest Hospital in Queensland, Australia Acquires Multiple Accuray Radixact® Systems with the ClearRT™ Helical Fan-Beam kVCT Imaging and Synchrony® Technologies

Accuray Incorporated (NASDAQ: ARAY) announced today that Royal Brisbane and Women's Hospital (RBWH), the largest medical facility in Queensland,...

Feb 10, 2022, 07:30 ET Accuray TomoTherapy® Helical Radiotherapy System Helps Preserve Breast Cancer Patients' Long-term Heart and Lung Functionality

Accuray Incorporated (NASDAQ: ARAY) announced today that data from a phase III, randomized controlled trial, TomoBreast, indicate post-surgery...

Feb 07, 2022, 17:30 ET Accuray to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the virtual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools...

Jan 26, 2022, 16:05 ET Accuray Reports Fiscal 2022 Second Quarter Financial Results

Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the second quarter of fiscal 2022 ended December 31, 2021. Second Quarter...

Jan 12, 2022, 16:05 ET Accuray to Report Second Quarter Fiscal 2022 Financial Results on January 26, 2022

Accuray Incorporated (NASDAQ: ARAY) will report financial results for the second quarter of fiscal year 2022, ended December 31, 2021, after the...

Dec 15, 2021, 07:30 ET Accuray CyberKnife® Robotic Radiosurgery System Receives Shonin Approval to Treat Trigeminal Neuralgia, a Chronic Pain Condition Affecting a Facial Nerve

Accuray Incorporated (NASDAQ: ARAY) announced today it has received approval from the Japanese Ministry of Health, Labor and Welfare (Shonin) to...

Nov 10, 2021, 07:30 ET Accuray CyberKnife® Robotic Radiotherapy Platform Expands Range of Neurological Indications That Can Be Effectively Treated With Stereotactic Radiosurgery

Accuray Incorporated (NASDAQ: ARAY) announced today that more than two decades of globally-driven clinical data support the use of the company's...

Nov 09, 2021, 09:00 ET Accuray To Participate at Stifel 2021 Virtual Healthcare Conference

Accuray Incorporated (Nasdaq: ARAY) today announced its participation in Stifel's 2021 Virtual Healthcare Conference. The management team is...

Nov 03, 2021, 16:05 ET Accuray Reports Fiscal 2022 First Quarter Financial Results

Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the first quarter of fiscal 2022 ended September 30, 2021. First Quarter...

Oct 25, 2021, 07:30 ET Accuray CyberKnife® Robotic Radiotherapy Platform Could Significantly Improve Survival in Early-Stage Breast Cancer Patients

Accuray Incorporated (NASDAQ: ARAY) announced today that a study published in Frontiers in Oncology found early-stage breast cancer patients could...

Oct 21, 2021, 16:05 ET Accuray Announces Preliminary First Quarter Fiscal 2022 Financial Results and Raises FY22 Revenue Guidance to range between $420 million to $427 million

Accuray Incorporated (NASDAQ: ARAY), today announced preliminary financial results for the first quarter of fiscal 2022 ended September 30, 2021....

Oct 19, 2021, 07:30 ET Accuray Unveils VOLO™ Ultra, the Latest Innovation for the Radixact® System, at ASTRO 2021

Accuray Incorporated (NASDAQ: ARAY) announced today the company is showcasing its new VOLO™ Ultra for the Radixact® System, at ASTRO 2021. VOLO...

Oct 13, 2021, 07:30 ET Accuray to Report First Quarter Fiscal 2022 Financial Results on November 3, 2021

Accuray Incorporated (NASDAQ: ARAY) will report financial results for the first quarter of fiscal year 2022, ended September 30, 2021, after the...

Oct 12, 2021, 07:30 ET Accuray to Host ASTRO Analyst & Investor Meeting on October 25, 2021

Accuray Incorporated (NASDAQ: ARAY) announced today that the company will host an Analyst & Investor Meeting on Monday, October 25, 2021, in...